Risk of heart failure up in ALVSD patients with diabetes

July 27, 2018

(HealthDay)—For patients with asymptomatic left ventricular systolic dysfunction (ALVSD), those with diabetes have increased risk of heart failure development and hospitalization, according to a study published in the June issue of Diabetes Care.

Rasmus Rørth, M.D., from the University of Glasgow in the United Kingdom, and colleagues examined the development of symptomatic heart failure, heart failure hospitalization, and according to baseline diabetes status in patients from the prevention arm of the Studies of Left Ventricular Dysfunction.

Overall, 15 percent of the 4,223 eligible participants had diabetes at baseline. The researchers found that 24 percent of the 3,567 patients without diabetes at baseline developed heart failure, compared with 33 percent of the 647 patients with diabetes during a median follow-up of 36 months. Patients with diabetes had an elevated risk for development of heart failure, heart failure hospitalization, and the composite outcome of development of heart failure or cardiovascular death (hazard ratios, 1.53, 2.04, and 1.48, respectively), in unadjusted analyses. Diabetes status did not modify the effect of enalapril on outcomes.

"In patients with ALVSD, is associated with an increased risk of developing heart failure, heart failure hospitalization and cardiovascular death," the authors write. "This information might help in the development of strategies to prevent the transition from ALVSD to overt ."

Explore further: In LVSD, diabetes tied to higher risk of heart failure

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

In LVSD, diabetes tied to higher risk of heart failure

April 20, 2018
(HealthDay)—In patients with asymptomatic left ventricular systolic dysfunction, diabetes is associated with an increased risk of developing heart failure, according to a study published online April 6 in Diabetes Care.

Elevated NT-proBNP found to up cardiovascular risk in T2DM

June 15, 2018
(HealthDay)—Elevated baseline N-terminal B-type natriuretic peptide (NT-proBNP) is independently associated with development of major cardiovascular (CV) events, in particular hospitalization for heart failure, according ...

Impact of T2DM meds on heart failure hospitalization explored

January 19, 2016
(HealthDay)—For patients with type 2 diabetes, there is no association between hospitalization for heart failure and treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) versus sulfonylureas (SUs) or treatment with ...

Risk conferred by T2D modified by HbA1c in heart failure

October 12, 2017
(HealthDay)—For patients with heart failure, the risks conferred by type 2 diabetes (T2D) can be stratified by glycemic control and drug treatments, according to a study published online Oct. 11 in JACC: Heart Failure.

Death rates from heart failure higher for women than men

July 16, 2018
Death rates from heart failure are higher for women than men, and hospitalization rates have increased in women while declining in men, found a study from the University of Ottawa Heart Institute published in CMAJ (Canadian ...

Diabetes may have important effects in patients with acute heart failure

June 26, 2017
Researchers have found that patients with acute heart failure and diabetes, compared with those without diabetes, have distinct markers related to inflammation, cardiovascular function, and kidney health.

Recommended for you

A novel insulin accelerant

October 17, 2018
Insulin levels rise after eating a meal, signaling uptake of circulating glucose by skeletal muscle. In individuals with diabetes this process is often impaired—a condition known as insulin resistance.

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.